뒤로
Innovent Biologics, Inc.(1801.HK) 가격
1801.HK 주가 차트
INNOVENT BIO (1801.HK)
Innovent Biologics, Inc.
HK$85.6
-2.94%
$-2.6
정규장: Jan 19, 15:47:09 HKT
주요 통계
이전 종가
$89.5
시가
$88.2
일일 범위
$83.6 - $89.35
52주 범위
$30.75 - $109.1
거래량
12.7M
평균 거래량
14.1M
EPS(TTM)
0.74
배당수익률
--
시가총액
$147.3B
INNOVENT BIO란 무엇인가요?
Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 6,190 full-time employees. The company went IPO on 2018-10-31. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The firm mainly conducts its businesses within domestic and overseas markets.